M. Cobo

616 total citations
20 papers, 342 citations indexed

About

M. Cobo is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, M. Cobo has authored 20 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 5 papers in Surgery. Recurrent topics in M. Cobo's work include Lung Cancer Treatments and Mutations (4 papers), Mycobacterium research and diagnosis (3 papers) and Lung Cancer Diagnosis and Treatment (3 papers). M. Cobo is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Mycobacterium research and diagnosis (3 papers) and Lung Cancer Diagnosis and Treatment (3 papers). M. Cobo collaborates with scholars based in Spain, United Kingdom and United States. M. Cobo's co-authors include J.L. Patier de la Peña, Bartomeu Massutí, Miguel F. Carrascosa, Mônica Rodrigues Campos, Antonio Cuadrado, Amelia Insa, F. Cardenal, Luis Paz‐Ares, R. Rosell and Enriqueta Felip and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

M. Cobo

19 papers receiving 332 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Cobo Spain 8 215 199 93 53 39 20 342
José María Duque Spain 9 144 0.7× 272 1.4× 86 0.9× 12 0.2× 80 2.1× 14 426
Shinichiro Muro Japan 12 220 1.0× 162 0.8× 211 2.3× 29 0.5× 44 1.1× 33 374
Angélica Hernández-Guerrero Mexico 9 100 0.5× 80 0.4× 168 1.8× 14 0.3× 22 0.6× 41 265
Ming-Shiang Wu Taiwan 8 225 1.0× 180 0.9× 233 2.5× 12 0.2× 15 0.4× 15 430
Kuniyasu Irie Japan 11 119 0.6× 61 0.3× 191 2.1× 23 0.4× 16 0.4× 33 281
Masaki Katsurahara Japan 11 248 1.2× 102 0.5× 320 3.4× 42 0.8× 10 0.3× 58 472
Kynan Feeney Australia 12 94 0.4× 179 0.9× 77 0.8× 7 0.1× 24 0.6× 28 308
Sam Li‐Sheng Chen Taiwan 4 148 0.7× 130 0.7× 152 1.6× 11 0.2× 13 0.3× 6 298
Axel Hsu Hong Kong 8 134 0.6× 110 0.6× 163 1.8× 33 0.6× 9 0.2× 10 314
Ana García García de Paredes Spain 10 121 0.6× 82 0.4× 193 2.1× 9 0.2× 12 0.3× 51 285

Countries citing papers authored by M. Cobo

Since Specialization
Citations

This map shows the geographic impact of M. Cobo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Cobo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Cobo more than expected).

Fields of papers citing papers by M. Cobo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Cobo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Cobo. The network helps show where M. Cobo may publish in the future.

Co-authorship network of co-authors of M. Cobo

This figure shows the co-authorship network connecting the top 25 collaborators of M. Cobo. A scholar is included among the top collaborators of M. Cobo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Cobo. M. Cobo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Felip, Enriqueta, V. Minotti, Julius Wolf, et al.. (2021). P76.03 Efficacy and Safety of Capmatinib Plus Nivolumab in Pretreated Patients with EGFR Wild-Type Non–Small Cell Lung Cancer. Journal of Thoracic Oncology. 16(3). S585–S586. 4 indexed citations
2.
Rizvi, Naiyer A., Niels Reinmuth, K.H. Lee, et al.. (2018). Durvalumab with or without tremelimumab vs platinum-based chemotherapy as first-line treatment for metastatic non-small cell lung cancer: MYSTIC. Annals of Oncology. 29. x40–x41. 74 indexed citations
3.
4.
García, Andrés González, M. Cobo, & J.L. Patier de la Peña. (2016). Current diagnosis and treatment of Castleman's disease. Revista Clínica Española (English Edition). 216(3). 146–156. 6 indexed citations
5.
García, Andrés González, M. Cobo, & J.L. Patier de la Peña. (2015). Diagnóstico y tratamiento actual de la enfermedad de Castleman. Revista Clínica Española. 216(3). 146–156. 8 indexed citations
6.
Peña, J.L. Patier de la, et al.. (2014). Enfermedad de Behçet y pioderma gangrenoso refractario a terapia convencional con respuesta a infliximab. Revista Clínica Española. 215(1). 66–67. 3 indexed citations
7.
Caballero, Juan de Dios, et al.. (2014). 102 Fungal colonization in the airways of Spanish cystic fibrosis patients: results from a multicenter study. Journal of Cystic Fibrosis. 13. S72–S72. 1 indexed citations
8.
Caballero, Juan de Dios, Rosa del Campo, M. Cobo, et al.. (2014). 59 Population structure and antimicrobial susceptibility of Pseudomonas aeruginosa from a national survey involving 24 cystic fibrosis units in Spain. Journal of Cystic Fibrosis. 13. S61–S61. 1 indexed citations
9.
Cobo, M., et al.. (2013). [Purple urine bag syndrome in elderly woman with nutritional supplements].. PubMed. 27(6). 2130–2. 4 indexed citations
10.
Cuadrado, Antonio, Miguel F. Carrascosa, Trinidad Dierssen‐Sotos, et al.. (2012). Levofloxacin versus clarithromycin in a 10 day triple therapy regimen for first-line Helicobacter pylori eradication: a single-blind randomized clinical trial. Journal of Antimicrobial Chemotherapy. 67(9). 2254–2259. 19 indexed citations
11.
Cuadrado, Antonio, Miguel F. Carrascosa, I. Monteagudo, et al.. (2011). Antimicrobial susceptibility of Helicobacter pylori to six antibiotics currently used in Spain. Journal of Antimicrobial Chemotherapy. 67(1). 170–173. 60 indexed citations
12.
13.
Peña, J.L. Patier de la, et al.. (2010). Cervicalgia, tortícolis y poliglobulia como forma de presentación de un hemangioblastoma cerebeloso. Revista Clínica Española. 210(6). e21–e23. 2 indexed citations
14.
Cobo, M., Bartomeu Massutí, Teresa Morán, et al.. (2008). Spanish customized adjuvant trial (SCAT) based on BRCA1 mRNA levels. Journal of Clinical Oncology. 26(15_suppl). 7533–7533. 17 indexed citations
15.
Cobo, M., et al.. (2008). TUBERCULOUS PERITONITIS: AN EMERGING UNCOMMON EXTRAPULMONARY INFECTION CAUSED BY MYCOBACTERIUM TUBERCULOSIS. European Journal of Internal Medicine. 19. S36–S37.
16.
Cobo, M., F. Cardenal, Amelia Insa, et al.. (2007). Skin rash as surrogate marker of efficacy in patients with non-small cell lung cancer treated with erlotinib. Journal of Clinical Oncology. 25(18_suppl). 7602–7602. 6 indexed citations
17.
Peña, J.L. Patier de la, et al.. (2007). Rabdomiólisis producida por la asociación de sinvastatina y risperidona. Medicina Clínica. 129(11). 439–439. 8 indexed citations
18.
Cobo, J., Jesús Oliva, Ángel Asensio, et al.. (2001). Predicting Tuberculosis Among HIV-Infected Patients Admitted to Hospital: Comparison of a Model with Clinical Judgment of Infectious Disease Specialists. European Journal of Clinical Microbiology & Infectious Diseases. 20(11). 779–784. 11 indexed citations
19.
Carabantes, F., et al.. (1999). Analysis of the effect of chemotherapy (CT) on erythropoietin (EPO) synthesis in cancer patients (PTS). European Journal of Cancer. 35. S364–S365. 1 indexed citations
20.
Carabantes, F., et al.. (1999). Epoetin alfa (EPO) prevents anaemia and improves quality of life (QOL) in cancer patients (PTS) undergoing platinum-based chemotherapy (CT). European Journal of Cancer. 35. S365–S365. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by José María Duque Breakdown of academic impact, for papers by Shinichiro Muro Breakdown of academic impact, for papers by Angélica Hernández-Guerrero Breakdown of academic impact, for papers by Ming-Shiang Wu Breakdown of academic impact, for papers by Kuniyasu Irie Breakdown of academic impact, for papers by Masaki Katsurahara Breakdown of academic impact, for papers by Kynan Feeney Breakdown of academic impact, for papers by Sam Li‐Sheng Chen Breakdown of academic impact, for papers by Axel Hsu Breakdown of academic impact, for papers by Ana García García de Paredes
Rankless by CCL
2026